The Outsourcing Facilities Association (OFA) alleged the agency was “abruptly depriving patients of much needed treatment and artificially raising drug prices.” Compounders had been allowed to ...
Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs.